Schembri Emanuel, Massalha Victoria, Spiteri Karl, Camilleri Liberato, Lungaro-Mifsud Stephen
Physiotherapy Outpatients, Karin Grech Hospital, Pieta, Malta.
Master of Science (MSc) Candidate, MSc Clinical Management of Pain (Headache), University of Edinburgh, Edinburgh, UK.
Korean J Pain. 2020 Oct 1;33(4):359-377. doi: 10.3344/kjp.2020.33.4.359.
This study investigated whether current smoking and a higher nicotine dependency were associated with chronic low back pain (LBP), lumbar related leg pain (sciatica) and/or radicular neuropathic pain.
A cross-sectional study was conducted on 150 patients (mean age, 60.1 ± 13.1 yr). Demographic data, the International Association for the Study of Pain (IASP) neuropathic pain grade, STarT Back tool, and the Fagerström test were completed. A control group (n = 50) was recruited.
There was a significant difference between current smokers and nonsmokers in the chronic LBP group in the mean pain score ( = 0.025), total STarT Back score ( = 0.015), worst pain location ( = 0.020), most distal pain radiation ( = 0.042), and in the IASP neuropathic pain grade ( = 0.026). There was a significant difference in the mean Fagerström score between the four IASP neuropathic pain grades ( = 0.005). Current smoking yielded an odds ratio (OR) of 3.071 ( = 0.011) for developing chronic LBP and sciatica, and an OR of 4.028 ( = 0.002) for obtaining an IASP "definite/probable" neuropathic pain grade, for both cohorts. The likelihood for chronic LBP and sciatica increased by 40.9% ( = 0.007), while the likelihood for an IASP neuropathic grade of "definite/probable" increased by 50.8% ( = 0.002), for both cohorts, for every one unit increase in the Fagerström score.
A current smoking status and higher nicotine dependence increase the odds for chronic LBP, sciatica and radicular neuropathic pain.
本研究调查了当前吸烟情况及更高的尼古丁依赖是否与慢性下腰痛(LBP)、腰椎相关腿痛(坐骨神经痛)和/或神经根性神经病理性疼痛相关。
对150例患者(平均年龄60.1±13.1岁)进行了一项横断面研究。完成了人口统计学数据、国际疼痛研究协会(IASP)神经病理性疼痛分级、STarT Back工具和法格斯特龙测试。招募了一个对照组(n = 50)。
在慢性LBP组中,当前吸烟者与非吸烟者在平均疼痛评分(P = 0.025)、STarT Back总分(P = 0.015)、最严重疼痛部位(P = 0.020)、最远端疼痛放射(P = 0.042)以及IASP神经病理性疼痛分级(P = 0.026)方面存在显著差异。在四个IASP神经病理性疼痛分级之间,平均法格斯特龙评分存在显著差异(P = 0.005)。对于两个队列,当前吸烟导致发生慢性LBP和坐骨神经痛的比值比(OR)为3.071(P = 0.011),获得IASP“明确/可能”神经病理性疼痛分级的OR为4.028(P = 0.002)。对于两个队列,法格斯特龙评分每增加一个单位,慢性LBP和坐骨神经痛的可能性增加40.9%(P = 0.007),而IASP神经病理性分级为“明确/可能”的可能性增加50.8%(P = 0.002)。
当前吸烟状态和更高的尼古丁依赖会增加慢性LBP、坐骨神经痛和神经根性神经病理性疼痛的几率。